Literature DB >> 31851811

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Reply.

Satoshi Yasuda1, Hisao Ogawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31851811     DOI： 10.1056/NEJMc1914049

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  [84/f with spondylodiscitis and multiple medications : Preparation for the medical specialist examination: part 110].

Authors:  K Faehling; M Denkinger
Journal:  Internist (Berl)       Date:  2021-10-20       Impact factor: 0.743

Review 2.  Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.

Authors:  Davide Capodanno; Deepak L Bhatt; John W Eikelboom; Keith A A Fox; Tobias Geisler; C Michael Gibson; Jose Ramon Gonzalez-Juanatey; Stefan James; Renato D Lopes; Roxana Mehran; Gilles Montalescot; Manesh Patel; P Gabriel Steg; Robert F Storey; Pascal Vranckx; Jeffrey I Weitz; Robert Welsh; Uwe Zeymer; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2020-01-17       Impact factor: 32.419

3.  Management of stable coronary artery disease and atrial fibrillation with anti-thrombotic therapy: A systematic review and meta-analysis.

Authors:  Srikanth Malladi; Kewan Hamid; Nitin Chandra Pendyala; Vijaysai Veerapaneni; Smit Deliwala; Donald Dubre; Samir A Elian; Adiraj Singh
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.